Microcatheter to recanalization (procedure time) predicts outcomes in endovascular treatment in patients with acute ischemic stroke: When do we stop?

American Journal of Neuroradiology

Volumn 34, Issue 2, 2013, Pages 354-359

  Hassan, Ameer E ^a   Chaudhry, S A ^a   Miley, J T ^a   Khatri, R ^a   Hassan, S A ^a   Suri, M F K ^a   Qureshi, A I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLACEBO; PROUROKINASE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CATHETER; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCATHETER; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; RECANALIZATION; TREATMENT DURATION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; DATABASES, FACTUAL; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MECHANICAL THROMBOLYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRACTOLOL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

EID: 84876172362     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3202     Document Type: Article

References (23)

1. Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers: Brain Attack Coalition. JAMA 2000;283:3102-09 (Pubitemid 30399721)
2. Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597-616 (Pubitemid 40973803)
3. Schriger DL, Kalafut M, Starkman S, et al. Cranial computed tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy. JAMA 1998;279:1293-97 (Pubitemid 28180783)
4. Hussein HM, Georgiadis AL, Vazquez G, et al. Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. AJNR Am J Neuroradiol 2010;31:454-58
5. Miley JT, Memon MZ, Hussein HM, et al. A multicenter analysis of "time to microcatheter" for endovascular therapy in acute ischemic stroke. J Neuroimaging 2011;21:159-64
6. Burns TC, Rodriguez GJ, Patel S, et al. Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: a case-control study. AJNR Am J Neuroradiol 2008;29:1918-24
7. Qureshi AI, Janjua N, Kirmani JF, et al. Mechanical disruption of thrombus following intravenous tissue plasminogen activator for ischemic stroke. J Neuroimaging 2007;17:124-30 (Pubitemid 46624153)
8. Qureshi AI, Harris-Lane P, Kirmani JF, et al. Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study. Neurosurgery 2006;59:789-96, discussion 96-97
9. Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:322-28 (Pubitemid 38235318)
10. Qureshi AI, Hussein HM, Abdelmoula M, et al. Subacute recanalization and reocclusion in patients with acute ischemic stroke following endovascular treatment. Neurocrit Care 2009;10:195-203
11. Qureshi AI, Suri MF, Ali Z, et al. Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke: a preliminary feasibility and safety study in a non-human primate model. Neuroradiology 2005;47:845-54. (Pubitemid 41693208)
12. Hassan AE, Zacharatos H, Rodriguez GJ, et al. A comparison of computed tomography perfusion-guided and time-guided endovascular treatments for patients with acute ischemic stroke. Stroke 2010;41:1673-78
13. Qureshi AI, Suri MF, Shatla AA, et al. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerating dosing regimen. Neurosurgery 2000;47:473-76, discussion 477-79
14. Qureshi AI, Ali Z, Suri MF, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001;49:41-48, discussion 48-50
15. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study - a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
16. Khatri P, Abruzzo T, Yeatts SD, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-72
17. Leifer D, Bravata DM, Connors JJ 3rd, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations - a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:849-77
18. Derex L, Adeleine P, Nighoghossian N, et al. Factors influencing early admission in a French stroke unit. Stroke 2002;33:153-59 (Pubitemid 34052203)
19. Nguyen TN, Lanthier S, Roy D. Iatrogenic arterial perforation during acute stroke interventions. AJNR Am J Neuroradiol 2008;29:974-75 (Pubitemid 351684977)
20. Shi ZS, Liebeskind DS, Loh Y, et al. Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy. Stroke 2010;41:2775-81
21. Nguyen TN, Babikian VL, Romero R, et al. Intra-arterial treatment methods in acute stroke therapy. Front Neurol 2011;2:9
22. Qureshi AI, Alkawi A, Hussein HM, et al. Angiographic analysis of intravascular thrombus volume in patients with acute ischemic stroke. J Endovasc Ther 2007;14:475-82 (Pubitemid 350154993)
23. Broderick JP, Lu M, Kothari R, et al. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke 2000;31:2335-41